Different Effects of Resveratrol on Dose-Related Doxorubicin-Induced Heart and Liver Toxicity
出版年份 2012 全文链接
标题
Different Effects of Resveratrol on Dose-Related Doxorubicin-Induced Heart and Liver Toxicity
作者
关键词
-
出版物
Evidence-based Complementary and Alternative Medicine
Volume 2012, Issue -, Pages 1-10
出版商
Hindawi Limited
发表日期
2012-11-27
DOI
10.1155/2012/606183
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Redox Imbalance and the Reduction of Contractile Protein Content in Rat Hearts Administered with L-Thyroxine and Doxorubicin
- (2012) Agnieszka Korga et al. Oxidative Medicine and Cellular Longevity
- Desferrioxamine Attenuates Doxorubicin-Induced Acute Cardiotoxicity through TFG-β/Smad p53 Pathway in Rat Model
- (2012) Othman A. Al-Shabanah et al. Oxidative Medicine and Cellular Longevity
- Clinical trials of resveratrol
- (2011) Ketan R. Patel et al. Annals of the New York Academy of Sciences
- Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro
- (2011) A. M. Al-Abd et al. CELL PROLIFERATION
- Resveratrol Improves Oxidative Stress and Protects Against Diabetic Nephropathy Through Normalization of Mn-SOD Dysfunction in AMPK/SIRT1-Independent Pathway
- (2011) M. Kitada et al. DIABETES
- Hepatic Glucuronidation of Resveratrol: Interspecies Comparison of Enzyme Kinetic Profiles in Human, Mouse, Rat, and Dog
- (2011) Alexandra Maier-Salamon et al. Drug Metabolism and Pharmacokinetics
- Resveratrol and health - A comprehensive review of human clinical trials
- (2011) James M. Smoliga et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Resveratrol Restores Nrf2 Level and Prevents Ethanol-Induced Toxic Effects in the Cerebellum of a Rodent Model of Fetal Alcohol Spectrum Disorders
- (2011) A. Kumar et al. MOLECULAR PHARMACOLOGY
- Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2
- (2010) Zoltan Ungvari et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Endothelial Nrf2 activation: a new target for resveratrol?
- (2010) György Haskó et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy
- (2010) Y. Zhao et al. CANCER RESEARCH
- Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation
- (2010) Amy V. Pointon et al. PLoS One
- Cardiomyocyte death in doxorubicin-induced cardiotoxicity
- (2009) Yi-Wei Zhang et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats
- (2009) Karol L. Thompson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway
- (2009) Elizabeth D. Brookins Danz et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: Effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide
- (2009) Mauro Feola et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma
- (2009) Daniel J. Luther et al. INVESTIGATIONAL NEW DRUGS
- Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets
- (2008) Vilma A. Sardão et al. CELL BIOLOGY AND TOXICOLOGY
- Dietary trans-resveratrol bioavailability and effect on CCl4-induced liver lipid peroxidation
- (2008) Paola Vitaglione et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started